by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Fagron BV Warning Letter Details

Warning Letter

Fagron BV

Fascinatio Boulevard 350 3065 WB Rotterdam Netherlands

Issue DateMay 12, 2026

FEI NumberN/A

Violations7

CountryNetherlands

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

Compounding Pharmacy/Adulterated Drug Products

Fagron BV FDA Warning Letter, May 12, 2026